Dawn Bowers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dawn Bowers has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Lindsey Kirsch-Darrow
Department of Physical Medicine and Rehabilitation, Division of Rehabilitation Psychology and Neuropsychology, John Hopkins University, Baltimore, MD, USA
4 shared publications- Michael Okun
School of Psychology, University of Sheffield, Sheffield, UK
4 shared publications Hubert Fernandez
3 shared publications- Michael Scott Okun
University of Florida
3 shared publications Utaka Springer
3 shared publications- Charles E. Jacobson
Department of Neurology, University of Florida, Gainesville, Florida, USA
2 shared publications
Latest Publications
- 4 July 2015
- Published by Taylor & Francis in The Clinical Neuropsychologist
- Vol. 29 (5) , 689-706
Neurocognitive Profile of a Woman with Susac’s Syndrome: Further Evidence of Cognitive Variability
Objective: Susac’s syndrome is a rare autoimmune disease characterized by encephalopathy, retinal artery occlusions, hearing loss, and lesions to the corpus callosum. To date, only four papers (five cases) have described the neuropsychological effects of the syndrome. Extant case reports of Susac’s syndrome have documented varying levels of cognitive impairment; some studies have identified diffuse cerebral dysfunction, while others describe more focal impairments in attention, memory, and executive functioning. Method: The goal of this case study was to provide comprehensive neurocognitive data obtained from another case of confirmed Susac’s syndrome. As such, we present the case of a 42-year-old woman with a two-year history of Susac’s syndrome. At the time of the neuropsychological evaluation, the patient described ongoing difficulties with memory, word-finding problems, problems with math, and poor problem-solving. Physical/sensory changes included hearing loss, tinnitus, and migraines. Results: Neuropsychological test results revealed the patient to be a woman of estimated average to high average premorbid intellect who exhibited a number of focal inefficiencies in the context of a generally intact profile. Particular cognitive weaknesses emerged on select tasks involving visuoconstruction, encoding of a wordlist, and bilateral speeded finger oscillations. She also committed three failures to maintain set on a task of cognitive flexibility. There was no evidence of memory deficits. Conclusions: Our findings provide further evidence of cognitive interindividual variability in a confirmed case of Susac’s syndrome.
- 4 July 2015
- Published by Taylor & Francis in The Clinical Neuropsychologist
- Vol. 29 (5) , 689-706
Neurocognitive Profile of a Woman with Susac’s Syndrome: Further Evidence of Cognitive Variability
Objective: Susac’s syndrome is a rare autoimmune disease characterized by encephalopathy, retinal artery occlusions, hearing loss, and lesions to the corpus callosum. To date, only four papers (five cases) have described the neuropsychological effects of the syndrome. Extant case reports of Susac’s syndrome have documented varying levels of cognitive impairment; some studies have identified diffuse cerebral dysfunction, while others describe more focal impairments in attention, memory, and executive functioning. Method: The goal of this case study was to provide comprehensive neurocognitive data obtained from another case of confirmed Susac’s syndrome. As such, we present the case of a 42-year-old woman with a two-year history of Susac’s syndrome. At the time of the neuropsychological evaluation, the patient described ongoing difficulties with memory, word-finding problems, problems with math, and poor problem-solving. Physical/sensory changes included hearing loss, tinnitus, and migraines. Results: Neuropsychological test results revealed the patient to be a woman of estimated average to high average premorbid intellect who exhibited a number of focal inefficiencies in the context of a generally intact profile. Particular cognitive weaknesses emerged on select tasks involving visuoconstruction, encoding of a wordlist, and bilateral speeded finger oscillations. She also committed three failures to maintain set on a task of cognitive flexibility. There was no evidence of memory deficits. Conclusions: Our findings provide further evidence of cognitive interindividual variability in a confirmed case of Susac’s syndrome.
- 1 January 2012
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 2 (2) , 161-166
Dimensions of Apathy in Parkinson's Disease: Exploratory Factor Analysis of the Apathy Scale
Apathy, an intrinsic disorder of motivation, can manifest in cognitive, affective, and behavioral domains. Recent attempts to formalize diagnostic criteria for apathy have advocated this triadic structure. The Apathy Scale (AS) is the only recommende
- 1 January 2012
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 2 (2) , 161-166
Dimensions of Apathy in Parkinson's Disease: Exploratory Factor Analysis of the Apathy Scale
Apathy, an intrinsic disorder of motivation, can manifest in cognitive, affective, and behavioral domains. Recent attempts to formalize diagnostic criteria for apathy have advocated this triadic structure. The Apathy Scale (AS) is the only recommende
- 1 May 2008
- Vol. 13, 5316-22
Does deep brain stimulation induce apathy in Parkinson's disease?
Chronic deep brain stimulation (DBS) is an important therapeutic advancement for the treatment of motor symptoms in Parkinson's disease (PD). However, its effects on non-motor symptoms are not well understood. Several studies have reported motivational disturbances and apathy after DBS surgery. Recent studies are beginning to more carefully examine the relationship between DBS and apathy. This review summarizes and evaluates the current state of the literature on apathy after DBS surgery, discusses methodological limitations in the literature, and makes suggestions for future research.
- 1 May 2008
- Vol. 13, 5316-22
Does deep brain stimulation induce apathy in Parkinson's disease?
Chronic deep brain stimulation (DBS) is an important therapeutic advancement for the treatment of motor symptoms in Parkinson's disease (PD). However, its effects on non-motor symptoms are not well understood. Several studies have reported motivational disturbances and apathy after DBS surgery. Recent studies are beginning to more carefully examine the relationship between DBS and apathy. This review summarizes and evaluates the current state of the literature on apathy after DBS surgery, discusses methodological limitations in the literature, and makes suggestions for future research.
- 1 January 2008
- Published by American Psychological Association (APA)
Effect of motor symptom onset asymmetry on facial expressivity
- 1 January 2008
- Published by American Psychological Association (APA)
Effect of motor symptom onset asymmetry on facial expressivity
- 1 July 2006
- Published by Cambridge University Press (CUP) in Journal of the International Neuropsychological Society
- Vol. 12 (6) , 765-773
Faces of emotion in Parkinsons disease: Micro-expressivity and bradykinesia during voluntary facial expressions
In humans, the neural circuitry underlying facial expressions differs, depending on whether facial expressions are spontaneously (i.e., limbic, subcortical) or voluntarily initiated (i.e., frontal cortex). Previous investigators have suggested that the “masked face” of Parkinson's disease involves spontaneous, but not intentional, facial expressions. In contrast, we hypothesized that intentional facial expressions may be slowed (bradykinetic) and involve less movement, in much the same way that other intentional movements are affected by Parkinson's disease. To test this hypothesis, we used sophisticated computer imaging techniques to quantify dynamic facial movement. Relative to controls, Parkinson patients had reduced facial movement (entropy) and were significantly slowed in reaching a peak expression (i.e., bradykinesia). These findings are consistent with the view that the basal ganglia play a role in affecting intentional facial movements. This possibly occurs because of diminished efficiency and/or activation of face representation areas in the frontal cortical regions (i.e., motor, premotor, and supplementary motor area) or because of movement-based suppression secondary to dopaminergic reduction in frontostriatal pathways. Taken together, the characterization of Parkinson's disease as a model system for the neuroanatomic dissociation between voluntary and spontaneous expressions may be unjustified. (JINS, 2006, 12, 765–773.)
- 1 July 2006
- Published by Cambridge University Press (CUP) in Journal of the International Neuropsychological Society
- Vol. 12 (6) , 765-773
Faces of emotion in Parkinsons disease: Micro-expressivity and bradykinesia during voluntary facial expressions
In humans, the neural circuitry underlying facial expressions differs, depending on whether facial expressions are spontaneously (i.e., limbic, subcortical) or voluntarily initiated (i.e., frontal cortex). Previous investigators have suggested that the “masked face” of Parkinson's disease involves spontaneous, but not intentional, facial expressions. In contrast, we hypothesized that intentional facial expressions may be slowed (bradykinetic) and involve less movement, in much the same way that other intentional movements are affected by Parkinson's disease. To test this hypothesis, we used sophisticated computer imaging techniques to quantify dynamic facial movement. Relative to controls, Parkinson patients had reduced facial movement (entropy) and were significantly slowed in reaching a peak expression (i.e., bradykinesia). These findings are consistent with the view that the basal ganglia play a role in affecting intentional facial movements. This possibly occurs because of diminished efficiency and/or activation of face representation areas in the frontal cortical regions (i.e., motor, premotor, and supplementary motor area) or because of movement-based suppression secondary to dopaminergic reduction in frontostriatal pathways. Taken together, the characterization of Parkinson's disease as a model system for the neuroanatomic dissociation between voluntary and spontaneous expressions may be unjustified. (JINS, 2006, 12, 765–773.)
- Open Access
- 9 June 2006
- Published by Oxford University Press (OUP) in Brain
- Vol. 129 (12) , 3356-3365
Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli
The amygdala is closely linked to basal ganglia circuitry and plays a key role in danger detection and fear-potentiated startle. Based on recent findings of amygdalar abnormalities in Parkinson's disease, we hypothesized that non-demented patients with this illness would show blunted reactivity during aversive/unpleasant events, as indexed by diminished emotional modulation of the startle eyeblink response. To test this hypothesis, 23 idiopathic patients with Parkinson's disease and 17 controls viewed standardized sets of aversive, pleasant and neutral pictures for 6 s each. During this time, white noise bursts (50 ms, 95 db) were binaurally presented to elicit startle eyeblink responses, measured from electrodes over the orbicularis oculi. After viewing each picture, subjects provided ratings of valence and arousal. The Parkinson's disease patients were in the early to middle stages of their disease, not demented or depressed, and were tested ‘on’ dopaminergic medication. The two groups were similar in age, education, gender and cognitive screening status. The control group had larger startle responses when viewing negative, aversive pictures than neutral or pleasant pictures. As predicted, startle enhancement during aversive pictures was significantly muted in the Parkinson's disease patients. This blunting was not due to abnormalities in the mechanics of the startle eyeblink per se. Nor was it related to depression symptoms, medications (psychotropics), or failure to perceive/appreciate the negative meaning of aversive pictures (i.e. normal valence ratings). Reduced startle reactivity in the disease group was related to disease severity (Hoehn–Yahr) and occurred in the context of reduced arousal ratings of aversive pictures. These findings of blunted startle reactivity add to the literature on emotional changes associated with Parkinson's disease. The basis for this muted reactivity is unknown but may involve an amygdala-based translational defect whereby the results of cognitive appraisal are not appropriately transcoded into somato-motor-arousal responses normally associated with an aversive motivational state. This may arise from faulty dopaminergic gating of the amygdala, resulting in ‘inhibition’ of the amygdala in the manner described by Marowsky et al. (Marowsky A, Yanagawa Y, Obata K, Vogt E. Neuron 2005; 48: 1025–37). More broadly, the findings of muted reactivity to aversive stimuli may reflect a ‘bradylimbic’ affective disturbance in patients with Parkinson's disease. Future studies are needed to address whether the physiologic blunting observed here might be a useful correlate of apathy.
- 9 June 2006
- Published by Oxford University Press (OUP) in Brain
- Vol. 129 (12) , 3356-3365
Open AccessStartling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli
The amygdala is closely linked to basal ganglia circuitry and plays a key role in danger detection and fear-potentiated startle. Based on recent findings of amygdalar abnormalities in Parkinson's disease, we hypothesized that non-demented patients with this illness would show blunted reactivity during aversive/unpleasant events, as indexed by diminished emotional modulation of the startle eyeblink response. To test this hypothesis, 23 idiopathic patients with Parkinson's disease and 17 controls viewed standardized sets of aversive, pleasant and neutral pictures for 6 s each. During this time, white noise bursts (50 ms, 95 db) were binaurally presented to elicit startle eyeblink responses, measured from electrodes over the orbicularis oculi. After viewing each picture, subjects provided ratings of valence and arousal. The Parkinson's disease patients were in the early to middle stages of their disease, not demented or depressed, and were tested ‘on’ dopaminergic medication. The two groups were similar in age, education, gender and cognitive screening status. The control group had larger startle responses when viewing negative, aversive pictures than neutral or pleasant pictures. As predicted, startle enhancement during aversive pictures was significantly muted in the Parkinson's disease patients. This blunting was not due to abnormalities in the mechanics of the startle eyeblink per se. Nor was it related to depression symptoms, medications (psychotropics), or failure to perceive/appreciate the negative meaning of aversive pictures (i.e. normal valence ratings). Reduced startle reactivity in the disease group was related to disease severity (Hoehn–Yahr) and occurred in the context of reduced arousal ratings of aversive pictures. These findings of blunted startle reactivity add to the literature on emotional changes associated with Parkinson's disease. The basis for this muted reactivity is unknown but may involve an amygdala-based translational defect whereby the results of cognitive appraisal are not appropriately transcoded into somato-motor-arousal responses normally associated with an aversive motivational state. This may arise from faulty dopaminergic gating of the amygdala, resulting in ‘inhibition’ of the amygdala in the manner described by Marowsky et al. (Marowsky A, Yanagawa Y, Obata K, Vogt E. Neuron 2005; 48: 1025–37). More broadly, the findings of muted reactivity to aversive stimuli may reflect a ‘bradylimbic’ affective disturbance in patients with Parkinson's disease. Future studies are needed to address whether the physiologic blunting observed here might be a useful correlate of apathy.
- 1 January 2006
- Published by American Psychological Association (APA)
Apathy and Executive Function in Nondemented Parkinson's Disease
- 1 January 2006
- Published by American Psychological Association (APA)
Apathy and Executive Function in Nondemented Parkinson's Disease
- 1 January 2006
- Published by American Psychological Association (APA)
Neuropsychological Profile of Essential Tremor
- 1 January 2006
- Published by American Psychological Association (APA)
Neuropsychological Profile of Essential Tremor